<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2313-8955-2017-3-3-51-56</article-id><article-id pub-id-type="publisher-id">1179</article-id><article-categories><subj-group subj-group-type="heading"><subject>Medicine (miscellaneous)</subject></subj-group></article-categories><title-group><article-title>TERMS OF EMERGENCE OF THE MAIN CLINICAL SYMPTOMS OF PREECLAMPSIA AT THE PRESENT STAGE</article-title><trans-title-group xml:lang="en"><trans-title>TERMS OF EMERGENCE OF THE MAIN CLINICAL SYMPTOMS OF PREECLAMPSIA AT THE PRESENT STAGE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Simanov</surname><given-names>Igor V.</given-names></name><name xml:lang="en"><surname>Simanov</surname><given-names>Igor V.</given-names></name></name-alternatives><email>simigor1@rambler.ru</email></contrib></contrib-group><pub-date pub-type="epub"><year>2017</year></pub-date><volume>3</volume><issue>3</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2017/3/51-56.pdf" /><abstract xml:lang="ru"><p>The purpose of the research was to study the terms of appearance of the first clinical symptoms of preeclampsia in 300 patients of fertile age with preeclampsia of varying severity and duration. The data of the research showed, that the more severe preeclampsia was, the earlier were diagnosed its first clinical symptoms. With &amp;quot;combined&amp;quot; preeclampsia, its clinical manifestations were diagnosed earlier than with &amp;quot;pure&amp;quot; ones. As the gestation period increased, the disease progressed. The duration of the course of &amp;quot;light&amp;quot; forms of preeclampsia up to the time of delivery averaged from 3 to 4 weeks, &amp;quot;medium&amp;quot; &amp;ndash; from 5 to 6 weeks, &amp;quot;heavy&amp;quot; &amp;ndash; more than 6 weeks. The knowledge of these processes, in my opinion, will allow to develop an optimal recovery therapy in the postpartum period, which can improve the &amp;quot;remote&amp;quot; forecast.</p></abstract><trans-abstract xml:lang="en"><p>The purpose of the research was to study the terms of appearance of the first clinical symptoms of preeclampsia in 300 patients of fertile age with preeclampsia of varying severity and duration. The data of the research showed, that the more severe preeclampsia was, the earlier were diagnosed its first clinical symptoms. With &amp;quot;combined&amp;quot; preeclampsia, its clinical manifestations were diagnosed earlier than with &amp;quot;pure&amp;quot; ones. As the gestation period increased, the disease progressed. The duration of the course of &amp;quot;light&amp;quot; forms of preeclampsia up to the time of delivery averaged from 3 to 4 weeks, &amp;quot;medium&amp;quot; &amp;ndash; from 5 to 6 weeks, &amp;quot;heavy&amp;quot; &amp;ndash; more than 6 weeks. The knowledge of these processes, in my opinion, will allow to develop an optimal recovery therapy in the postpartum period, which can improve the &amp;quot;remote&amp;quot; forecast.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>pregnancy</kwd><kwd>preeclampsia</kwd><kwd>toxicosis</kwd><kwd>threatened miscarriage</kwd><kwd>premature birth</kwd><kwd>premature detachment of the normally located placenta</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pregnancy</kwd><kwd>preeclampsia</kwd><kwd>toxicosis</kwd><kwd>threatened miscarriage</kwd><kwd>premature birth</kwd><kwd>premature detachment of the normally located placenta</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>1. Eilamazyan E.K. Obstetrics. National leadership. M.: &amp;quot;GEOTAR-Media&amp;quot;, 2009. 1200 p.</mixed-citation></ref><ref id="B2"><mixed-citation>2. Eilamazyan E.K., Mozgovaya E.V. Gestosis: theory and practice. M.: &amp;quot;MEDPRESS-INFORM&amp;quot;, 2008. 264 p.</mixed-citation></ref><ref id="B3"><mixed-citation>3. Vikhlyaeva E.M. Preclinical manifestations of systemic disorders, clinical outcomes and long-term consequences of preeclampsia // Obstetrics and Gynecology. 2009. (3) 1. Pp. 3-6.</mixed-citation></ref><ref id="B4"><mixed-citation>4. Odnokozova O.S., Vasilenko L.V., Zryachkin N.I. The course of pregnancy, childbirth and the state of health of newborns after the preventive treatment of gestosis in pregnant women at risk // Saratov Journal of Medical Scientific Research. 2009. (4) 5. Pp. 533-536.</mixed-citation></ref><ref id="B5"><mixed-citation>5. Pathogenesis of gestosis as a manifestation of the immunocomplex pathology of the endothelium (acute immune endotheliosis). Sidorova I.S., Gurina O.I., Milovanov A.P., Nikitina N.A., Bardachova A.V., Shemanaeva T.V. Obstetrics and gynecology. 2008. 6. Pp. 13-17.</mixed-citation></ref><ref id="B6"><mixed-citation>6. Prokopenko V.M. The role of oxidative stress in the pathogenesis of gestosis. Obstetrics and Gynecology. 2007. 4. Pp. 31-36.</mixed-citation></ref><ref id="B7"><mixed-citation>7. Savelyeva G.M. Obstetrics. M .: Publishing Group &amp;quot;GEOTAR-Media&amp;quot;, 2008. 651 p.</mixed-citation></ref><ref id="B8"><mixed-citation>8. Savelyeva G.M., Serov V.N., Sukhikh G.T. Clinical recommendations. Obstetrics and gynecology. Moscow: GEOTAR-Media, 2009. 868 p.</mixed-citation></ref><ref id="B9"><mixed-citation>9. Sidorova I.S. Kulakov V.I., Makarov I.O. 2008. Assessment of the severity of gestosis (according to the literature). Obstetrics and gynecology. 3. Pp. 40-43.</mixed-citation></ref><ref id="B10"><mixed-citation>10. Sidorova I.S. Zayratyants O.V., Nikitina N.A. Gestosis and maternal mortality. Obstetrics and gynecology. 2008. 2. Pp. 13-15.</mixed-citation></ref><ref id="B11"><mixed-citation>11. Block A., Dana M., Turan, O. More First-Trimester Risk Factors for Preeclampsia Development in Women Initiating Aspirin by 16 Weeks of Gestation. Obstetrics &amp;amp; Gynecology. 2014. Vol. 123(3). Pp. 611-617.</mixed-citation></ref><ref id="B12"><mixed-citation>12. Lisonkova S., Yasser S. Chantal M. Maternal Morbidity Associated With Early-Onset and Late-Onset Preeclampsia. Obstetrics &amp;amp; Gynecology. 2014. Vol.124(4). Pp. 771-781.</mixed-citation></ref><ref id="B13"><mixed-citation>13. Mostello D., Jen C., Allen J. More Recurrent Preeclampsia: The Effect of Weight Change Between Pregnancies. Obstetrics &amp;amp; Gynecology. 2010. 116(3). Pp. 667-672.</mixed-citation></ref></ref-list></back></article>